Annual SG&A
$61.45M$11.58M-15.86%
Summary
- Current Value
- As of today, ALVO annual SG&A is $61.45M, down -15.86% on
- Historical Performance
- ALVO annual SG&A is down -26.96% over the past 3 years, and up +26.54% over the past 5 years
- All-Time High Comparison
- ALVO annual SG&A is currently -66.49% below its historical high of $183.39M set on
- 3-Year Low Comparison
- ALVO annual SG&A is at its 3-year low
- Sector Comparison
- ALVO annual SG&A is higher than 77.35% of companies in Healthcare sector
SG&A Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual SG&A | $61.45M | -15.9% | -27.0% | +26.5% | +26.5% | |
| Quarterly SG&A | $51.62M | +205.8% | +197.1% | +10000.0% | +10000.0% | |
| TTM SG&A | -$9.36B | -10000.0% | -5997.8% | -10000.0% | -10000.0% | |
| Price | $5.24 | -60.1% | -56.1% | – | – | |
| Annual Operating Expenses | $234.73M | -17.8% | -13.8% | +151.4% | +151.4% | |
| Annual Operating Profit | $69.64M | +119.6% | +129.6% | +213.3% | +213.3% | |
| Annual D&A | $31.30M | +29.3% | +72.0% | +114.3% | +114.3% | |
| Annual Revenue | $489.68M | +435.6% | +100.0% | +1434.2% | +1434.2% |
SG&A Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $183.39M | N/A | -66.5% |
| 5Y | $183.39M | -66.5% | |
| All | $183.39M | -66.5% |
SG&A Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $61.45M | at low | |
| 5Y | $58.91M | N/A | +4.3% |
| All | $48.57M | +26.5% |
SG&A History
| Year | Value | Change |
|---|---|---|
| $61.45M | -15.9% | |
| $73.04M | -60.2% | |
| $183.39M | +118.0% |
| Year | Value | Change |
|---|---|---|
| $84.13M | +42.8% | |
| $58.91M | +21.3% | |
| $48.57M | - |
FAQ
What is the current annual SG&A of ALVO?
As of today, ALVO annual SG&A is $61.45M
What is 1-year change in ALVO annual SG&A?
ALVO annual SG&A is down -15.86% year-over-year
What is 3-year change in ALVO annual SG&A?
ALVO annual SG&A is down -26.96% over the past 3 years
How far is ALVO annual SG&A from its all-time high?
ALVO annual SG&A is currently -66.49% below its historical high of $183.39M set on December 31, 2022
How does ALVO annual SG&A rank versus sector peers?
ALVO annual SG&A is higher than 77.35% of companies in Healthcare sector
When is ALVO next annual earnings release?
The next annual earnings release for ALVO is on
Quarterly SG&A
$51.62M$22.66M-30.51%
Summary
- Current Value
- As of today, ALVO quarterly SG&A is $51.62M, down -30.51% on
- Historical Performance
- ALVO quarterly SG&A is up +205.78% year-over-year, and up +197.12% over the past 3 years
- All-Time High Comparison
- ALVO quarterly SG&A is currently -55.10% below its historical high of $114.97M set on
- 3-Year Low Comparison
- ALVO quarterly SG&A is +266.98% above its 3-year low of $14.07M reached on
- Sector Comparison
- ALVO quarterly SG&A is higher than 86.67% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly SG&A | $51.62M | -30.5% | +205.8% | +197.1% | +10000.0% | |
| Annual SG&A | $61.45M | – | -15.9% | -27.0% | +26.5% | |
| TTM SG&A | -$9.36B | -7355.4% | -10000.0% | -5997.8% | -10000.0% | |
| Price | $5.24 | -35.7% | -60.1% | -56.1% | – | |
| Quarterly Operating Expenses | $77.54M | -4.8% | +53.7% | +32.5% | +10000.0% | |
| Quarterly Operating Profit | $1.20M | -93.3% | -90.5% | +101.9% | +3456.7% | |
| Quarterly D&A | $10.28M | +15.6% | +22.4% | – | – | |
| Quarterly Revenue | $113.74M | -34.3% | +10.6% | +497.0% | +100.0% |
Quarterly SG&A Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $74.28M | -30.5% | |
| 3Y | $74.28M | -30.5% | |
| 5Y | $114.97M | -55.1% | |
| All | $114.97M | -55.1% |
Quarterly SG&A Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $18.61M | +177.4% | |
| 3Y | $14.07M | +267.0% | |
| 5Y | $235.30K | N/A | >+9999.0% |
| All | $35.60K | >+9999.0% |
Quarterly SG&A History
FAQ
What is the current quarterly SG&A of ALVO?
As of today, ALVO quarterly SG&A is $51.62M
What is ALVO quarterly SG&A most recent change?
ALVO quarterly SG&A was down -30.51% on September 30, 2025
What is 1-year change in ALVO quarterly SG&A?
ALVO quarterly SG&A is up +205.78% year-over-year
How far is ALVO quarterly SG&A from its all-time high?
ALVO quarterly SG&A is currently -55.10% below its historical high of $114.97M set on June 30, 2022
How does ALVO quarterly SG&A rank versus sector peers?
ALVO quarterly SG&A is higher than 86.67% of companies in Healthcare sector
When is ALVO next earnings release?
The next earnings release for ALVO is on
TTM SG&A
-$9.36B$69.50M+0.74%
Summary
- Current Value
- As of today, ALVO TTM SG&A is -$9.36B, up +0.74% on
- Historical Performance
- ALVO TTM SG&A is down -14630.65% year-over-year, and down -5997.75% over the past 3 years
- All-Time High Comparison
- ALVO TTM SG&A is currently -26751248.57% below its historical high of -$35.00K set on an earlier date
- 3-Year Low Comparison
- ALVO TTM SG&A is +2.39% above its 3-year low of -$9.59B reached on an earlier date
- Sector Comparison
- ALVO TTM SG&A is higher than 3.25% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM SG&A | -$9.36B | -7355.4% | -10000.0% | -5997.8% | -10000.0% | |
| Annual SG&A | $61.45M | – | -15.9% | -27.0% | +26.5% | |
| Quarterly SG&A | $51.62M | -30.5% | +205.8% | +197.1% | +10000.0% | |
| Price | $5.24 | -35.7% | -60.1% | -56.1% | – | |
| TTM Operating Profit | $18.17M | -38.6% | +138.3% | +106.8% | +10000.0% | |
| TTM D&A | $35.59M | +5.6% | +19.2% | – | – | |
| TTM Revenue | $548.10M | +2.0% | +49.2% | +826.3% | +100.0% |
TTM SG&A Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$9.36B | N/A | at high |
| 3Y | -$4.33B | N/A | -116.0% |
| 5Y | -$29.11M | N/A | >-9999.0% |
| All | -$35.00K | N/A | >-9999.0% |
TTM SG&A Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$9.59B | N/A | +2.4% |
| 3Y | -$9.59B | N/A | +2.4% |
| 5Y | -$9.59B | N/A | +2.4% |
| All | -$9.59B | N/A | +2.4% |
TTM SG&A History
FAQ
What is the current TTM SG&A of ALVO?
As of today, ALVO TTM SG&A is -$9.36B
What is ALVO TTM SG&A most recent change?
ALVO TTM SG&A was up +0.74% on September 30, 2025
What is 1-year change in ALVO TTM SG&A?
ALVO TTM SG&A is down -14630.65% year-over-year
How does ALVO TTM SG&A rank versus sector peers?
ALVO TTM SG&A is higher than 3.25% of companies in Healthcare sector
When is ALVO next earnings release?
The next earnings release for ALVO is on
Selling, General & Administrative Expenses Formula
SG&A = − − R&D
Data Sources & References
- ALVO Official Website www.alvotech.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1898416/000162828025015052/0001628280-25-015052-index.htm
- ALVO Profile on Yahoo Finance finance.yahoo.com/quote/ALVO
- ALVO Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/alvo